Literature DB >> 25314221

Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype.

Tanya K Murphy1, Priyal D Patel, Joseph F McGuire, Allison Kennel, P Jane Mutch, E Carla Parker-Athill, Camille E Hanks, Adam B Lewin, Eric A Storch, Megan D Toufexis, Gul H Dadlani, Carina A Rodriguez.   

Abstract

OBJECTIVE: Pediatric acute-onset neuropsychiatric syndrome (PANS) is a subtype of obsessive compulsive disorder (OCD) marked by an abrupt onset or exacerbation of neuropsychiatric symptoms. We aim to characterize the phenotypic presentation of youth with PANS.
METHODS: Forty-three youth (ages 4-14 years) meeting criteria for PANS were assessed using self-report and clinician-administered measures, medical record reviews, comprehensive clinical evaluation, and laboratory measures.
RESULTS: Youth with PANS presented with an early age of OCD onset (mean=7.84 years) and exhibited moderate to severe obsessive compulsive symptoms upon evaluation. All had comorbid anxiety and emotional lability, and scored well below normative means on all quality of life subscales. Youth with elevated streptococcal antibody titers trended toward having higher OCD severity, and presented more frequently with dilated pupils relative to youth without elevated titers. A cluster analysis of core PANS symptoms revealed three distinct symptom clusters that included core characteristic PANS symptoms, streptococcal-related symptoms, and cytokine-driven/physiological symptoms. Youth with PANS who had comorbid tics were more likely to exhibit a decline in school performance, visuomotor impairment, food restriction symptoms, and handwriting deterioration, and they reported lower quality of life relative to youth without tics.
CONCLUSIONS: The sudden, acute onset of neuropsychiatric symptoms, high frequency of comorbidities (i.e., anxiety, behavioral regression, depression, and suicidality), and poor quality of life capture the PANS subgroup as suddenly and severely impaired youth. Identifying clinical characteristics of youth with PANS will allow clinicians to diagnose and treat this subtype of OCD with a more strategized and effective approach.

Entities:  

Mesh:

Year:  2014        PMID: 25314221      PMCID: PMC4340632          DOI: 10.1089/cap.2014.0062

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  32 in total

1.  Comparison of clinical features among youth with tic disorders, obsessive-compulsive disorder (OCD), and both conditions.

Authors:  Adam B Lewin; Susanna Chang; James McCracken; Melissa McQueen; John Piacentini
Journal:  Psychiatry Res       Date:  2010-05-21       Impact factor: 3.222

2.  Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  Tanya K Murphy; Eric A Storch; Adam B Lewin; Paula J Edge; Wayne K Goodman
Journal:  J Pediatr       Date:  2011-08-25       Impact factor: 4.406

3.  Neurocognitive functioning in youth with pediatric autoimmune neuropsychiatric disorders associated with streptococcus.

Authors:  Adam B Lewin; Eric A Storch; P Jane Mutch; Tanya K Murphy
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

4.  Gender differences in obsessive-compulsive symptom dimensions.

Authors:  Javier Labad; Jose Manuel Menchon; Pino Alonso; Cinto Segalas; Susana Jimenez; Nuria Jaurrieta; James F Leckman; Julio Vallejo
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

5.  Comparison of clinical characteristics of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and childhood obsessive-compulsive disorder.

Authors:  Gail A Bernstein; Andrea M Victor; Allison J Pipal; Kyle A Williams
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

Review 6.  Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder.

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-01       Impact factor: 8.829

7.  Defining clinical severity in pediatric obsessive-compulsive disorder.

Authors:  Adam B Lewin; John Piacentini; Alessandro S De Nadai; Anna M Jones; Tara S Peris; Gary R Geffken; Daniel A Geller; Joshua M Nadeau; Tanya K Murphy; Eric A Storch
Journal:  Psychol Assess       Date:  2013-12-09

8.  Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children.

Authors:  Douglas L Leslie; Laura Kozma; Andrés Martin; Angeli Landeros; Liliya Katsovich; Robert A King; James F Leckman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-10       Impact factor: 8.829

9.  Quality of life in children and adolescents with obsessive-compulsive disorder: base rates, parent-child agreement, and clinical correlates.

Authors:  Caleb W Lack; Eric A Storch; Mary L Keeley; Gary R Geffken; Emily D Ricketts; Tanya K Murphy; Wayne K Goodman
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-03       Impact factor: 4.328

10.  Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection.

Authors:  Anna C Nilsson; Per Björkman; Kenneth Persson
Journal:  BMC Microbiol       Date:  2008-06-11       Impact factor: 3.605

View more
  20 in total

1.  Pediatric Acute-Onset Neuropsychiatric Syndrome Response to Oral Corticosteroid Bursts: An Observational Study of Patients in an Academic Community-Based PANS Clinic.

Authors:  Kayla Brown; Cristan Farmer; Bahare Farhadian; Joseph Hernandez; Margo Thienemann; Jennifer Frankovich
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-17       Impact factor: 2.576

2.  Special issue on pediatric acute-onset neuropsychiatric syndrome.

Authors:  Kiki Chang; Harold S Koplewicz; Ron Steingard
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02       Impact factor: 2.576

3.  A pilot trial of cognitive-behavioral therapy augmentation of antibiotic treatment in youth with pediatric acute-onset neuropsychiatric syndrome-related obsessive-compulsive disorder.

Authors:  Joshua M Nadeau; Cary Jordan; Robert R Selles; Monica S Wu; Morgan A King; Priyal D Patel; Camille E Hanks; Elysse B Arnold; Adam B Lewin; Tanya K Murphy; Eric A Storch
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-05       Impact factor: 2.576

4.  Immunoglobulin A Dysgammaglobulinemia Is Associated with Pediatric-Onset Obsessive-Compulsive Disorder.

Authors:  Kyle Williams; Leah Shorser-Gentile; Suraj Sarvode Mothi; Noah Berman; Mark Pasternack; Daniel Geller; Jolan Walter
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-03-20       Impact factor: 2.576

5.  Overview of Treatment of Pediatric Acute-Onset Neuropsychiatric Syndrome.

Authors:  Susan E Swedo; Jennifer Frankovich; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-19       Impact factor: 2.576

6.  Multidisciplinary clinic dedicated to treating youth with pediatric acute-onset neuropsychiatric syndrome: presenting characteristics of the first 47 consecutive patients.

Authors:  Jennifer Frankovich; Margo Thienemann; Jennifer Pearlstein; Amber Crable; Kayla Brown; Kiki Chang
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02       Impact factor: 2.576

7.  Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS Consensus Conference.

Authors:  Kiki Chang; Jennifer Frankovich; Michael Cooperstock; Madeleine W Cunningham; M Elizabeth Latimer; Tanya K Murphy; Mark Pasternack; Margo Thienemann; Kyle Williams; Jolan Walter; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-17       Impact factor: 2.576

8.  Predictors and Prospective Course of PANS: A Pilot Study Using Electronic Platforms for Data Collection.

Authors:  Elizabeth C Harris; Christine A Conelea; Michael T Shyne; Gail A Bernstein
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-12-31       Impact factor: 2.576

Review 9.  Developmental Considerations in Obsessive Compulsive Disorder: Comparing Pediatric and Adult-Onset Cases.

Authors:  Daniel A Geller; Saffron Homayoun; Gabrielle Johnson
Journal:  Front Psychiatry       Date:  2021-06-14       Impact factor: 4.157

10.  Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity.

Authors:  Jian Xu; Rong-Jian Liu; Shaylyn Fahey; Luciana Frick; James Leckman; Flora Vaccarino; Ronald S Duman; Kyle Williams; Susan Swedo; Christopher Pittenger
Journal:  Am J Psychiatry       Date:  2020-06-16       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.